FdaApplication

ANDA 211834

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTORRENT PHARMACEUTICALS LTD
application_typeANDA
approval_date2025-06-20

Products (3)

ProductActive ingredientStrengthDosage form
APREMILASTAPREMILAST10MGTABLET;ORAL
APREMILASTAPREMILAST20MGTABLET;ORAL
APREMILASTAPREMILAST30MGTABLET;ORAL

3 products